Rebecca R. Laborde

Centre National de la Recherche Scientifique — France

Medicine · Health Sciences

15h-index2.6kcitations56works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Immunotherapy and Biomarkers(15), Immune cells in cancer(15), Acute Myeloid Leukemia Research(12), RNA modifications and cancer(10), Head and Neck Cancer Studies(9)

Publications56 total

Improving Quality of Patient Educational Materials through a Comparative Analysis of Patient Handbooks from U.S. Transplant Centers
American Journal of Transplantation·2025
Design of a Neonatal Orthotopic Metastatic Xenograft Model of Hepatoblastoma in Mice
Oncology·2025· 1 cited
Supplemental Table 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Legend for Supplemental Figure 2legend from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Data from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 3 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 2 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 3 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 4 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Legend for Supplemental Figure 2legend from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Table 1 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Data from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
Supplemental Figure 4 from Intratumoral CD14<sup>+</sup> Cells and Circulating CD14<sup>+</sup>HLA-DR<sup>lo/neg</sup> Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
2023Open Access
A Pilot Study of the Telomerase Inhibitor Imetelstat for Myelofibrosis
New England Journal of Medicine·2015· 317 citedOpen Access
Intratumoral CD14+ Cells and Circulating CD14+HLA-DRlo/neg Monocytes Correlate with Decreased Survival in Patients with Clear Cell Renal Cell Carcinoma
Clinical Cancer Research·2015· 45 cited
page 1 of 3Next →

Frequent Co-authors

Eric J. Moore(18), Kerry D. Olsen(17), Yi Lin(15), Michael P. Gustafson(15), Peggy A. Bulur(15), Allan B. Dietz(15), Jonathan Bleeker(14), Deepti Warad(14), Matthew K. Tollefson(14), Paul L. Crispen(14), Susan M. Harrington(14), Bradley C. Leibovich(14), John C. Cheville(14), Eugene D. Kwon(14), Jan L. Kasperbauer(13), Jeremy C. Smith(12), Animesh Pardanani(11), Christy M. Finke(10), Ayalew Tefferi(10), Terra L. Lasho(10)